Pathological Hypersecretory Conditions

• FDA approval · 2023-09-29
  FDA Approved: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG — Original Application (MARKSANS PHARMA LIMITED)

  FDA approved Marksans Pharma Limited's esomeprazole magnesium delayed-release capsules, 20 mg, as a generic therapeutic option for common ac…

• FDA approval · 2021-06-04
  FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for Pantoprazole Sodium (Sun Pharmaceutical Industries, Inc.), resulting in updated labeling for…

• FDA approval · 2006-10-20
  FDA Approved: NEXIUM — Original Application (AstraZeneca Pharmaceuticals LP)

  FDA approved Nexium (esomeprazole magnesium) as AstraZeneca's original NDA. The approval established Nexium as a proton pump inhibitor for a…